Inverness Medical extends distribution agreement with Thermo Fisher

The co-exclusive agreement continues to cover all of the cardiology and drugs of abuse rapid test products manufactured by the Biosite subsidiary of Inverness and sold under the Triage brand including tests for brain natriuretic peptide (BNP), troponin, CK-MB, Myoglobin, d-dimer and a broad range of meter and visually read drugs of abuse tests.

However, products sold for use on third party instruments such as the BNP test sold by Inverness for use on Beckman immunoassay systems are not included.

Ron Zwanziger, CEO of Inverness, said: “Inverness has enjoyed a long and successful relationship with Thermo Fisher Scientific and very much values their expertise in distribution to the clinical laboratory. We are very pleased to extend this agreement for our Triage product line and look forward to a continuing strong affiliation.”